Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

被引：317

作者：

Powles, T. ^{[1
]}

Bellmunt, J. ^{[2
]}

Comperat, E. ^{[3
]}

De Santis, M. ^{[4
]}

Huddart, R. ^{[5
]}

Loriot, Y. ^{[6
,7
]}

Necchi, A. ^{[8
]}

Valderrama, B. P. ^{[9
]}

Ravaud, A. ^{[10
,11
]}

Shariat, S. F. ^{[12
]}

Szabados, B. ^{[1
,13
]}

van der Heijden, M. S. ^{[14
]}

Gillessen, S. ^{[15
]}

机构：

[1] Queen Mary Univ London, Barts Canc Ctr, Barts Hlth NHS Trust, London, England

[2] Harvard Med Sch, Beth Israel Deaconess Med Ctr, IMIM Lab, Boston, MA 02115 USA

[3] Hop Tenon, Assistance Publ Hop Paris, Paris, France

[4] Charite, Dept Urol, Berlin, Germany

[5] Royal Marsden Hosp, Inst Canc Res, London, England

[6] Univ Paris Saclay, Dept Med Oncol, Villejuif, France

[7] Gustave Roussy, Villejuif, France

[8] Univ Vita Salute San Raffaele, IRCCS San Raffaele Hosp, Dept Med Oncol, Milan, Italy

[9] Univ Hosp Virgen del Rocio, Seville, Spain

[10] Hop St Andre CHU, Bordeaux, France

[11] Bordeaux Univ Hosp, Dept Med Oncol, Bordeaux, France

[12] Med Univ Vienna, Vienna Gen Hosp, Dept Urol, Vienna, Austria

[13] Univ Coll London Hosp, Dept Urol, London, England

[14] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands

[15] EOC, Oncol Inst Southern Switzerland IOSI, Lugano, Switzerland

来源：

ANNALS OF ONCOLOGY | 2022年 / 33卷 / 03期

关键词：

immune checkpoint inhibitors; fibroblast growth factor receptor inhibitors; antibody drug conjugates; bladder cancer; urothelial carcinoma; platinum-based chemotherapy; METASTATIC UROTHELIAL CARCINOMA; BACILLUS-CALMETTE-GUERIN; PHASE-III TRIAL; TRANSITIONAL-CELL CARCINOMA; COMBINED-MODALITY TREATMENT; RADICAL CYSTECTOMY; OPEN-LABEL; SINGLE-ARM; ADJUVANT CHEMOTHERAPY; PREDICTING RECURRENCE;

D O I：

10.1016/j.annonc.2021.11.012

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：244 / 258

页数：15

共 121 条

[51] Adjuvant Chemotherapy for Invasive Bladder Cancer: A 2013 Updated Systematic Review and Meta-Analysis of Randomized Trials [J].

Leow, Jeffrey J. ;

Martin-Doyle, William ;

Rajagopal, Padma S. ;

Patel, Chirayu G. ;

Anderson, Erin M. ;

Rothman, Andrew T. ;

Cote, Richard J. ;

Urun, Yuksel ;

Chang, Steven L. ;

Choueiri, Toni K. ;

Bellmunt, Joaquim .

EUROPEAN UROLOGY, 2014, 66 (01) :42-54

[52] A RANDOMIZED COMPARISON OF CISPLATIN ALONE OR IN COMBINATION WITH METHOTREXATE, VINBLASTINE, AND DOXORUBICIN IN PATIENTS WITH METASTATIC UROTHELIAL CARCINOMA - A COOPERATIVE GROUP-STUDY [J].

LOEHRER, PJ ;

EINHORN, LH ;

ELSON, PJ ;

CRAWFORD, ED ;

KUEBLER, P ;

TANNOCK, I ;

RAGHAVAN, D ;

STUARTHARRIS, R ;

SAROSDY, MF ;

LOWE, BA ;

BLUMENSTEIN, B ;

TRUMP, D .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (07) :1066-1073

[53] Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma [J].

Loriot, Y. ;

Necchi, A. ;

Park, S. H. ;

Garcia-Donas, J. ;

Huddart, R. ;

Burgess, E. ;

Fleming, M. ;

Rezazadeh, A. ;

Mellado, B. ;

Varlamov, S. ;

Joshi, M. ;

Duran, I. ;

Tagawa, S. T. ;

Zakharia, Y. ;

Zhong, B. ;

Stuyckens, K. ;

Santiago-Walker, A. ;

De Porre, P. ;

O'Hagan, A. ;

Avadhani, A. ;

Siefker-Radtke, A. O. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (04) :338-348

[54] Prognostic Factors in Upper Urinary Tract Urothelial Carcinomas: A Comprehensive Review of the Current Literature [J].

Lughezzani, Giovanni ;

Burger, Maximilian ;

Margulis, Vitaly ;

Matin, Surena F. ;

Novara, Giacomo ;

Roupret, Morgan ;

Shariat, Shahrokh F. ;

Wood, Christopher G. ;

Zigeuner, Richard .

EUROPEAN UROLOGY, 2012, 62 (01) :100-114

[55] An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guerin for Non-Muscle-Invasive Bladder Cancer [J].

Malmstrom, Per-Uno ;

Sylvester, Richard J. ;

Crawford, David E. ;

Friedrich, Martin ;

Krege, Susanne ;

Rintala, Erkki ;

Solsona, Eduardo ;

Di Stasi, Savino M. ;

Witjes, J. Alfred .

EUROPEAN UROLOGY, 2009, 56 (02) :247-256

[56] Outcomes of Radical Nephroureterectomy: A Series From the Upper Tract Urothelial Carcinoma Collaboration [J].

Margulis, Vitally ;

Shariat, Shahrokh F. ;

Matin, Surena F. ;

Kamat, Ashish M. ;

Zigeuner, Richard ;

Kikuchi, Eiji ;

Lotan, Yair ;

Weizer, Alon ;

Raman, Jay D. ;

Wood, Christopher G. .

CANCER, 2009, 115 (06) :1224-1233

[57] Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer [J].

Massard, Christophe ;

Gordon, Michael S. ;

Sharma, Sunil ;

Rafii, Saeed ;

Wainberg, Zev A. ;

Luke, Jason ;

Curiel, Tyler J. ;

Colon-Otero, Gerardo ;

Hamid, Omid ;

Sanborn, Rachel E. ;

O'Donnell, Peter H. ;

Drakaki, Alexandra ;

Tan, Winston ;

Kurland, John F. ;

Rebelatto, Marlon C. ;

Jin, Xiaoping ;

Blake-Haskins, John A. ;

Gupta, Ashok ;

Segal, Neil H. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (26) :3119-+

[58] Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma [J].

Messer, Jamie ;

Shariat, Shahrokh F. ;

Brien, James C. ;

Herman, Michael P. ;

Ng, Casey K. ;

Scherr, Douglas S. ;

Scoll, Benjamin ;

Uzzo, Robert G. ;

Wille, Mark ;

Eggener, Scott E. ;

Steinberg, Gary ;

Terrell, John D. ;

Lucas, Steven M. ;

Lotan, Yair ;

Boorjian, Stephen A. ;

Raman, Jay D. .

BJU INTERNATIONAL, 2011, 108 (05) :701-705

[59] Cisplatin and gemcitabine administered every two weeks in patients with locally advanced or metastatic urothelial carcinoma and impaired renal function [J].

Morales-Barrera, Rafael ;

Bellmunt, Joaquim ;

Suarez, Cristina ;

Valverde, Claudia ;

Guix, Marta ;

Serrano, Cesar ;

Gallen, Manuel ;

Carles, Joan .

EUROPEAN JOURNAL OF CANCER, 2012, 48 (12) :1816-1821

[60]

Mourey L, 2020, J CLIN ONCOL, V38

← 1 2 3 4 5 6 7 8 9 10 →